Argentine President Alberto Fernandez at an Aug. 12, 2020 press conference (Juan Mabromata/Pool via AP)
Covid-19 roundup: Sorrento threatens to sue critic of their coronavirus ‘cure’; Novavax signs with SK bioscience
Sorrento Therapeutics has come under fire for how they’ve characterized their Covid-19 research, taking heat in May from researchers, bio-ethicists and even some investors …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.